On the in silico and in vitro anticancer activity of sulfonamide chalcones: potential JNKK3 inhibitors

Página do item simplificado
dc.creatorCustodio, Jean Marcos Ferreira
dc.creatorMoura, Andrea Felinto
dc.creatorMoraes Filho, Manoel Odorico de
dc.creatorNoda Pérez, Caridad
dc.creatorNapolitano, Hamilton Barbosa
dc.date.accessioned2023-08-22T10:16:30Z
dc.date.available2023-08-22T10:16:30Z
dc.date.issued2020
dc.description.abstractScience is constantly looking for new strategies to combat tumor progression and improve patient care due to increasing cancer incidence and high mortality. Although many chalcone analogues have been synthesized and studied because of their activity against tumor cell growth, the use of hybrid compounds containing both sulfonamides and chalcone moieties for this purpose is still scarce. Hereby, this work proposes a series of sulfonamide chalcones presenting biological potential against this disease. After being experimentally tested, these compounds showed cytotoxicity against tumor cell lines SF-295 and PC-3, which motivated us to investigate the possible structural bases for this action. Topological analyses were carried out through Hirshfeld analysis to assign intermolecular interaction sites important for protein–ligand analysis. To identify potential targets, the synthesized compounds were submitted to a structure-based pharmacophoric screening, which suggest strong potential activity as mitogen-activated protein kinase 10 (JKN3) inhibitors. Considering these results, these compounds were docked within the JKN3 active site. Our hypothesis that these compounds achieve their biological potential by inhibiting the JKN3 protein is reinforced when their energies of ligand–protein interaction were compared to co-crystallized ligands: they showed similar or even lower binding energies. Finally, the energy of the different conformations (solid phase, aqueous phase and within the protein active site) of these sulfonamide chalcones was investigated using theoretical calculations. Our findings enable further studies on more sulfonamide chalcone analogues toward the development of new anticancer drugs.pt_BR
dc.identifier.citationCUSTODIO, Jean M. F. et al. On the in silico and in vitro anticancer activity of sulfonamide chalcones: potential JNKK3 inhibitors. New Journal of Chemistry, London, v. 44, n. 8, p. 3294-3309, 2020. DOI: 10.1039/C9NJ05612B. Disponível em: https://pubs.rsc.org/en/content/articlelanding/2020/NJ/C9NJ05612B. Acesso em: 17 ago. 2023.pt_BR
dc.identifier.doi10.1039/C9NJ05612B
dc.identifier.issne- 1369-9261
dc.identifier.urihttps://pubs.rsc.org/en/content/articlelanding/2020/NJ/C9NJ05612B
dc.language.isoengpt_BR
dc.publisher.countryGra-bretanhapt_BR
dc.publisher.departmentInstituto de Química - IQ (RMG)pt_BR
dc.rightsAcesso Restritopt_BR
dc.titleOn the in silico and in vitro anticancer activity of sulfonamide chalcones: potential JNKK3 inhibitorspt_BR
dc.typeArtigopt_BR

Arquivos

Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

IQ - Artigos publicados em periódicos